The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials

• DOI: 10.1038/s41375-018-0272-0
• Publication Date: 2018-09-28T14:35:22Z
• Authors: Tobias W. Klausen; Henrik Gregersen; Niels Abildgaard; Niels Frost Andersen; Ulf Christian Frø...; Peter Gimsing; Carsten Helleberg; Annette J. Vangsted
• Keywords: Patient Selection; 03 medical and health sciences; 0302 clinical medicine; Clinical Trials, Phase III as Topic; Research Design; Phase III as Topic/statistics & numerical data; Humans; Clinical Trials; Multiple Myeloma/diagnosis; Guideline Adherence; Registries; Multiple Myeloma; Research Design/standards; Aged